Adam J. Smith

1.2k total citations
21 papers, 975 citations indexed

About

Adam J. Smith is a scholar working on Materials Chemistry, Physical and Theoretical Chemistry and Pharmaceutical Science. According to data from OpenAlex, Adam J. Smith has authored 21 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Materials Chemistry, 4 papers in Physical and Theoretical Chemistry and 3 papers in Pharmaceutical Science. Recurrent topics in Adam J. Smith's work include Crystallography and molecular interactions (4 papers), Crystallization and Solubility Studies (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Adam J. Smith is often cited by papers focused on Crystallography and molecular interactions (4 papers), Crystallization and Solubility Studies (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Adam J. Smith collaborates with scholars based in United States, United Kingdom and Qatar. Adam J. Smith's co-authors include R. Douglas Shytle, Michael J. Zaworotko, Łukasz Wojtas, P. Kavuru, Jun Tan, Brian Giunta, Paula C. Bickford, Michael W. Fountain, Naga Kiran Duggirala and Jingji Jin and has published in prestigious journals such as Nature, Nature Reviews Molecular Cell Biology and PLoS ONE.

In The Last Decade

Adam J. Smith

20 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam J. Smith United States 12 383 347 152 150 134 21 975
Shuai Qian China 23 553 1.4× 245 0.7× 386 2.5× 829 5.5× 195 1.5× 86 1.9k
Zhengzheng Zhou China 19 439 1.1× 353 1.0× 191 1.3× 83 0.6× 157 1.2× 47 885
Reiko Teraoka Japan 19 239 0.6× 105 0.3× 141 0.9× 230 1.5× 77 0.6× 50 843
Qin Shi China 21 485 1.3× 154 0.4× 223 1.5× 455 3.0× 102 0.8× 52 1.2k
Kazuo Tomono Japan 20 393 1.0× 145 0.4× 171 1.1× 448 3.0× 152 1.1× 74 1.2k
Toshiro Fukami Japan 21 572 1.5× 383 1.1× 179 1.2× 414 2.8× 181 1.4× 113 1.4k
Toyofumi Suzuki Japan 20 286 0.7× 132 0.4× 329 2.2× 487 3.2× 127 0.9× 90 1.3k
Yohei Kawabata Japan 16 509 1.3× 88 0.3× 326 2.1× 1.2k 7.9× 132 1.0× 25 1.9k
Ivana S. Lula Brazil 18 153 0.4× 47 0.1× 349 2.3× 269 1.8× 131 1.0× 39 976
P. Kuś Poland 16 291 0.8× 112 0.3× 173 1.1× 19 0.1× 199 1.5× 101 928

Countries citing papers authored by Adam J. Smith

Since Specialization
Citations

This map shows the geographic impact of Adam J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Smith more than expected).

Fields of papers citing papers by Adam J. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Smith. The network helps show where Adam J. Smith may publish in the future.

Co-authorship network of co-authors of Adam J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Smith. A scholar is included among the top collaborators of Adam J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Smith. Adam J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braeckman, Rene A., et al.. (2022). Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 32(5). 288–295. 15 indexed citations
2.
Mudie, Deanna M., et al.. (2021). Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs. Pharmaceutics. 13(4). 557–557. 6 indexed citations
3.
Mudie, Deanna M., Aaron M. Stewart, Adam J. Smith, et al.. (2020). A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets. International Journal of Pharmaceutics X. 2. 100042–100042. 37 indexed citations
4.
Mudie, Deanna M., Aaron M. Stewart, Kimberly B. Shepard, et al.. (2020). Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment. Molecular Pharmaceutics. 17(12). 4463–4472. 30 indexed citations
5.
Smith, Adam J., et al.. (2019). DO2A-based ligands for gallium-68 chelation: synthesis, radiochemistry and ex vivo cardiac uptake. Dalton Transactions. 49(4). 1097–1106. 11 indexed citations
7.
Smith, Adam J., Peter J. Gawne, Michelle Ma, et al.. (2018). Synthesis, gallium-68 radiolabelling and biological evaluation of a series of triarylphosphonium-functionalized DO3A chelators. Dalton Transactions. 47(43). 15448–15457. 7 indexed citations
8.
Jin, Jingji, Bethany Grimmig, Charles E. Hudson, et al.. (2016). HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo. Cell Transplantation. 25(11). 1967–1977. 25 indexed citations
10.
Smith, Adam J., Seol-Hee Kim, Jun Tan, et al.. (2014). Plasma and brain pharmacokinetics of previously unexplored lithium salts. RSC Advances. 4(24). 12362–12365. 12 indexed citations
11.
Duggirala, Naga Kiran, Adam J. Smith, Łukasz Wojtas, R. Douglas Shytle, & Michael J. Zaworotko. (2014). Physical Stability Enhancement and Pharmacokinetics of a Lithium Ionic Cocrystal with Glucose. Crystal Growth & Design. 14(11). 6135–6142. 71 indexed citations
12.
Smith, Adam J., P. Kavuru, Kapildev K. Arora, et al.. (2013). Crystal Engineering of Green Tea Epigallocatechin-3-gallate (EGCg) Cocrystals and Pharmacokinetic Modulation in Rats. Molecular Pharmaceutics. 10(8). 2948–2961. 73 indexed citations
13.
Smith, Adam J., Seol-Hee Kim, Naga Kiran Duggirala, et al.. (2013). Improving Lithium Therapeutics by Crystal Engineering of Novel Ionic Cocrystals. Molecular Pharmaceutics. 10(12). 4728–4738. 76 indexed citations
14.
Smith, Adam J., Brian Giunta, Paula C. Bickford, et al.. (2010). Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. International Journal of Pharmaceutics. 389(1-2). 207–212. 202 indexed citations
15.
Tan, Jun, Jared Ehrhart, Adam J. Smith, et al.. (2010). Effects of blue-green algae extracts on the proliferation of human adult stem cells in vitro: a preliminary study.. PubMed. 16(1). BR1–5. 9 indexed citations
16.
Smith, Adam J.. (2002). Getting to know the family. Nature. 418(6896). 455–455. 1 indexed citations
17.
Smith, Adam J.. (2002). How small should you go?. Nature. 418(6896). 457–457. 2 indexed citations
18.
Smaglik, Paul & Adam J. Smith. (2002). Riding the biotech rollercoaster. Nature. 418(6893). 4–5. 3 indexed citations
19.
Smith, Adam J.. (2001). In the face of resistance. Nature Reviews Molecular Cell Biology. 2(10). 714–714. 1 indexed citations
20.
Schachtel, Bernard, et al.. (1988). Ibuprofen Tablets Dissolution Versus Bioavailability. Drug Development and Industrial Pharmacy. 14(11). 1629–1645. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026